The future of the Affordable Care Act (“ACA” or “Obamacare”) is hinging on the outcome of King v. Burwell. The Supreme Court is expected to rule before the end of June and 6.5 million folks who currently receive subsidies, are nervously awaiting the decision. The promise of healthcare reform, i.e., that the uninsured would receive […]

A new report by IMS Institute for Healthcare Information announces U.S drug spending during 2014 at a record $374 billion. The record spend represented a 13% increase over 2013.  This should come as no surprise to prescription drug plan sponsors trying to control and reduce prescription drug costs.  They’ve watched as the predictions regarding specialty […]